The drip is saliva that has been through the portion and come back out carrying whatever dissolved — and swallowing it wastes most of the nicotine, but not all of it. Swallowed nicotine runs roughly a fifth to two-fifths as bioavailable as an injection, because your liver destroys most of it on the first pass. Germany’s federal risk institute addresses the question directly, and so, it turns out, does one manufacturer.
Everyone who has used snus knows the sensation and almost nobody can tell you what it is. The vernacular word for it does not appear in a single regulatory document, patent, manufacturer page or published paper I searched — seventeen documents, zero hits for “drip” and zero for “snus juice”. The reader has a word for this and the industry does not.
What the drip is, mechanically
A portion is a filter. Swedish Match’s own patent describes a pouch material that “holds the tobacco in place while allowing saliva to pass into the interior of the pouch”; Philip Morris’s puts it more completely — “the pouch membrane allows passage of saliva and prevents or inhibits passage of undissolved composition”. Saliva goes in, dissolved material comes out, the powder stays behind. The liquid in your mouth is the second half of that exchange.
What is dissolved in it comes from a short list, and the maker publishes it: “the main ingredients in the preparation of snus are water, salt (ordinary cooking salt) and sodium carbonate”, with aromatic compounds and moisture-preserving agents on top. The salt load has been measured — Swedish portion and loose snus run between 2.3 and 6.4% chloride, averaging about 3.5%, and 1.8 to 4.2% sodium — which is why the taste is the first thing people notice. The sodium carbonate is the alkali, and it is what makes the nicotine mobile: as Benowitz’s pharmacology review puts it, “Chewing tobacco and snuff are buffered to alkaline pH to facilitate absorption of nicotine through oral mucosa.” The German regulator measured a median pH of 8.8 across forty-four pouches, with 86% of the nicotine in free-base form. More on that chemistry in snus pH.
Why you salivate — and the surprise is that it probably isn’t the nicotine
This has been measured, in a way that answers the question better than you would expect. Eleven people who had never used tobacco were given six pouches in ascending dose — 0, 1.6, 3.2, 4.8, 6.4 and 8.0 mg of nicotine, forty-five minutes apart — and rated “excessive salivation” before and after each one. “Collapsed across dose, average ratings were 6.7 (SEM = 1.6) pre-pouch and 20.6 (SEM = 3.1) post-pouch”, and the ratings “increased significantly from pre- to post-pouch use (p <.05), independent of dose.”
Read the analysis rather than the headline. Salivation was significant on time (p=.035) and not significant on dose (p=.751), and the dose series included a nicotine-free placebo pouch. Rated salivation roughly tripled whether or not there was any nicotine in the thing. That is consistent with the drip being a response to having a salty, alkaline object under your lip rather than to the drug in it. Eleven people and a null result is weak evidence, so take it as consistent-with rather than demonstrated. The study was funded by a university psychology department and an NIH training grant, with no industry money — the cleanest funding on this page.
And the manufacturers are not neutral about it. Philip Morris’s pouch patent states that “a relatively low bulk density promotes effective salivation and thereby release of water-soluble ingredients of the composition.” The salivation is not a side effect being tolerated. It is engineered in, because it is the delivery mechanism. The pouch cannot work without it.
One calibration: in a crossover of fourteen smokers comparing a one-gram Swedish portion against 4 mg nicotine gum, “Salivation and throat burn were rated higher for the 4 mg NP gum compared with both types of snus.” Chewing gum out-salivates snus.
Acute up, chronic down — and a scope warning
Two older studies measured flow directly in snuff users. A 1991 Swedish study using a chewing model found that “the salivary flow was more than twice as high when chewing snuff compared to chewing with nothing in the mouth”, and a 1985 study of twenty-one users found that “The salivary flow of resting saliva showed a slightly significant increase compared to controls. That of stimulated saliva was not significantly increased among snuff users.”
The long-term literature mostly runs the other way, reporting reduced resting flow in habitual smokeless-tobacco users — but almost all of it concerns gutka, betel quid, naswar and shammah, South Asian and Middle Eastern products that are chewed, often with areca nut, and are not Swedish snus or nicotine pouches. Of the flow studies I could find, only the two above actually concern snus. Do not let a gutka flow rate stand in for a snus one, and do not take either direction as settled.
How much actually leaves the portion
This is measured, in vivo, and the number is lower than most people assume. Lunell’s trial, reproduced in BfR’s own table, had participants hold a portion for sixty minutes and then weighed the nicotine that had left it:
| Product | n | mg per portion | Nicotine extracted |
|---|---|---|---|
| Nicotine pouch | 17 | 3 mg | 1.59 mg (55.9%) |
| Nicotine pouch | 17 | 6 mg | 3.51 mg (59.1%) |
| Nicotine pouch | 30 | 8 mg | 3.79 mg (50.4%) |
| Swedish snus | 17 | 8 mg | 2.41 mg (32.0%) |
| Swedish snus | 30 | 2 × 8 mg | 5.04 mg (32.6%) |
| American snus | 30 | 18 mg | 2.99 mg (18.9%) |
A Swedish snus portion gives up about a third of its nicotine in an hour. Two thirds goes in the bin with the pouch. The published abstract puts it as “The extracted fractions of nicotine for both ZYN products (56% and 59%) were significantly larger than for 8 mg General (32%).” The study’s author list includes an affiliation at “Product Science, Swedish Match, Stockholm, Sweden”, and BfR notes of its pharmacokinetics table that “The first five studies were conducted by manufacturers or with financial support of manufacturers.” I could not obtain a verbatim funding statement from the paper itself.
Two cautions. First, a laboratory flow cell says something quite different: Altria’s dissolution work found 88 to 98% of the nicotine released in sixty minutes for most tobacco-free pouches. Same duration, roughly three times the figure. The rig is not a mouth. Second, extracted is not absorbed. BfR’s prose says the nicotine “is absorbed” where its own table column is headed “Extracted nicotine” — extraction is what left the portion, absorption is what crossed into your blood. Those are different quantities and the difference is exactly what this page is about. For the delivery side, see absorption, how fast it hits and how long it lasts.
Does swallowing it matter?
Here is the one regulator who addresses it, in two neutral sentences:
“Some of the nicotine may also be dissolved in saliva and then swallowed. This fraction can be reabsorbed in the gastrointestinal tract.”
That sits inside a passage saying that after sixty minutes of use “at least half of the nicotine contained in the pouch is absorbed by the body”, and that “The majority of the nicotine is absorbed directly via the oral mucosa.” Separately, BfR says “The pouches should not be swallowed” — note the scope: that is about the pouch, not the liquid.
And one manufacturer answers the question outright. ZYN’s own FAQ carries it as a heading: “Is it okay to swallow my saliva when using ZYN? While using ZYN, you may naturally swallow saliva. However, the pouch itself should not be swallowed.” That is the only first-party guidance on the subject I found anywhere.
So what happens to the fraction you swallow? Mostly, your liver eats it. Benowitz’s table gives nicotine’s bioavailability by route: 44% for an oral capsule, 20% for an oral solution, 15–25% by enema, against 100% intravenous. For products like gum and lozenges, “Bioavailability for these products with absorption mainly through the mucosa of the oral cavity and a considerable swallowed portion is about 50–80%”, and the reason is stated plainly: “The absolute dose of nicotine absorbed systemically from nicotine gum is much less than the nicotine content of the gum, in part, because considerable nicotine is swallowed with subsequent first-pass metabolism”.
The crispest sentence on the mechanism comes from a 2000 pharmacology paper: “Hepatic CYP2A6 accounts for nicotine’s low systemic bioavailability, precluding oral nicotine replacement to treat dependence.” The liver’s destruction of swallowed nicotine is so thorough that you cannot build an oral nicotine medicine out of it.
The closest thing to a mass balance comes from nicotine gum rather than snus. Benowitz’s 1987 study found that “Extraction of nicotine from gum by the chewer was incomplete, averaging 53% and 72% for 2 and 4 mg gum, and variable (more than twofold) among individuals”, and concluded that “Relative buccal absorption vs. swallowing of nicotine appears to be an important determinant of systemic nicotine intake.” A sublingual-tablet study found the same thing from the other direction: higher doses were “non-linear compared to the 2-mg dose, probably as a result of more of the dose being swallowed and undergoing first-pass metabolism in the liver.” The more you put in your mouth, the larger the share you swallow and waste — which is one real reason a stronger portion does not feel proportionally stronger.
No mass-balance study exists for snus or pouches. Lunell gives what left the portion and what appeared in blood, but nobody has partitioned the extracted fraction between cheek and gut for this product class. That is a genuine hole.
One counter-intuitive footnote. Nicotine is actively concentrated into saliva: “Accumulation is caused by ion-trapping of nicotine in gastric juice and saliva”, with measured saliva-to-plasma ratios of 11 during patch use and 87 while smoking. So some of the nicotine in your mouth arrived from your bloodstream rather than from the portion — though those ratios come from patch and cigarette studies, nobody has published the equivalent figure during snus use, and the number does not transfer.
Will swallowing it make you ill?
The honest answer is that nobody has studied the specific question, and the indirect evidence is reassuring in one dimension and not the other.
The indirect evidence first. BfR’s symptom tiers for nicotine: “Mild symptoms of intoxication include nausea and vomiting, with symptoms from higher levels of exposure including diarrhoea, increased salivation and a slowing of the heart rate.” And the single most useful data point on this page for a worried reader, from BfR’s poisonings committee: “In one case, a pouch with 20 mg nicotine had been swallowed.” The outcome — “The affected person was given activated charcoal by the emergency service team but did not develop any symptoms other than stomach pain.” A whole 20 mg pouch, swallowed, and the reported symptom was a sore stomach. The liquid in your mouth contains far less than that. That is not a safety claim about anything; it is a single reported case, reported by a regulator as a poisoning referral.
In BfR’s own clinical trial, with symptoms rated on a ten-point scale, “The scores given to the side effects of drowsiness, pounding heart, headache, throat irritation, sweating, dizziness, cold hands and feet, nausea and an urge to vomit were under 3 on average at each measurement interval.” Oral mucosa irritation, by contrast, was the one effect that was substantial — which is a different problem, and the subject of why some pouches burn and others don’t.
Now the gap. Nothing in any primary document connects the drip itself to nausea. The general nicotine-ingestion literature is about e-liquid and about tobacco-plant poisoning, not about swallowed snus saliva. Hiccups and heartburn, which come up constantly in forum advice, have no primary source at all — I looked and found none. If you feel queasy after swallowing a mouthful, the mechanism is plausible and sourced in outline and the specific link is folklore. Say it that way rather than pretending otherwise. Signs of too much nicotine covers the real warning signs.
One figure that sounds alarming and needs its scope stated: “In 2009, EFSA established an acute reference dose (ARfD) for nicotine of 0.0008 mg/kg bodyweight, applying an LOAEL of 0.0035 mg/kg bodyweight.” For a seventy-kilogram adult that is 0.056 mg of nicotine, which every pouch on the market exceeds by orders of magnitude, and BfR says as much: “If the ARfD value of 0.0008 mg/kg bodyweight is used, nicotine pouches containing all nicotine quantities presented in this report will be withdrawn from the market.” That reference dose was derived for nicotine as a food contaminant, in wild mushrooms, and BfR applies it because Germany classifies pouches as a novel food — not because it is a tobacco-product standard. The adverse effect behind it was an increase in heart rate of about seven beats a minute.
Why moist snus drips and dry products don’t
The industry’s own definitions are quantitative: “dry snuff has a water content of less than 10 wt% and moist snuff has a water content of above 40 wt%”, with semi-dry products between. And the mechanism that puts the water there is named in a Swedish Match patent: “In general, the smokeless tobacco composition or non-tobacco composition has a moisture content of 28-30% and the pouches are thereafter post-moisturized using a thin water beam to an end concentration of 48-51%.” That sentence sits inside a paragraph about seal-strength testing and describes general practice rather than a claim of the invention, so read it as the manufacturer’s own account of how it is done.
Measured by Karl Fischer titration, Swedish portion products run 39 to 46% water — General White 45.3, General 41.3, Granit White 39.1 — against two dry white products at 22.4 and 22.2. Tobacco-free pouches run far lower still, at 3.52, 3.71, 4.48 and 6.62% for four of seven measured. Across the category that is better than a tenfold range in how much liquid is in the thing under your lip, and it is the whole explanation for why one product soaks your mouth and another barely registers. See snus moisture levels and what is white dry snus.
One measurement caveat, because this is where published figures mislead: the oven method behind most “moisture” numbers drives off propylene glycol along with water. “In particular the oven method, commonly used to determine moisture in tobacco, gave significantly higher values than the Karl Fischer water method when propylene glycol was present”, with “an average error of 10–15%”. The useful control is that “Three brands of P Snus had no propylene glycol: Catch Dry White Eucalyptus Mini, Catch Dry White Licorice Mini and Wise Citrus and Menthol. These were also the brands with the lowest moisture levels.” And a correction to something this site has previously implied: the absence of glycol narrows the gap but does not close it. The oven-minus-Karl-Fischer gaps for those two products work out at 5.1 and 1.6 points, and 3.7 and −1.7 — one method reading lower than Karl Fischer — against 13.5 and 9.3 for ordinary General. That arithmetic is mine, not the paper’s conclusion. The study was funded by British American Tobacco and three authors were BAT employees at the time.
The patent that treats leakage as a problem — and whose problem it is
There is exactly one document I found that treats liquid escaping a portion as something to engineer against, and the twist is worth the whole section. A British American Tobacco patent application notes: “Due to the high moisture content of snus, and particularly when influenced by storage or packaging conditions, liquid can seep from the snus and result in dark or brown coloured spots on the fleece.” The fix, and its purpose: “One line of teachings has been directed at reducing the moisture in the snus, thereby reducing the likelihood of seepage or moisture migration which is a source of spotting”, and reduced-moisture snus “also avoids certain problems with snus clumping in the packing machinery.”
So the industry has spent real effort engineering against liquid leaving a portion — for brown stains on the fleece inside the tin, and for clogged packing machines. Not for your mouth. The dry product happens to drip less as a side effect nobody wrote down.
If anything, the maker treats the dry product’s behaviour as a defect. Swedish Match’s patent says the release of flavours and nicotine “may be delayed and/or diminished by the pouch material”, that the initial release “may be experienced by the consumer as unsatisfactory or even negligible”, and that “This problem is often more pronounced for non-post-moisturized oral pouched snuff products.” Philip Morris, from the other side, claims an advantage in pouches that “did not need any wetting before use as opposed to conventional nicotine pouches with low moisture content which may feel dry initially in use” — which is the only document I found behind the common practice of wetting a dry pouch to get it started.
One thing that is measured and turns out not to matter: the permeability of the bag. Pore sizes across seven pouch products span a factor of two, from 49 to 105 µm, and “These differences in pore size did not correlate with the dissolution” rates. What drives release in that data is the filler — its crystallinity, solubility and viscosity — not the fabric. Pouch fleece materials goes into the fabric itself.
So what do you actually do about it
Honestly: less than the internet suggests, because most of the advice has nothing behind it.
Swallowing is addressed by one manufacturer, which says you may naturally swallow the saliva, and by one regulator, which describes the swallowed fraction neutrally as reabsorbable. Neither tells you to spit. Spitting is what the category markets itself against — “spit-free” appears on ZYN’s and Rogue’s own pages as a product claim — and beyond that line no maker says anything about the liquid at all: a 1.3 MB ZYN page published in 2025 whose entire subject is the moisture level of nicotine pouches does not contain the words “saliva”, “swallow”, “spit” or “drip” even once. On the pharmacology, the swallowed fraction is mostly wasted rather than dangerous, so spitting costs you a little delivery and swallowing costs you a little comfort, and neither is a health decision on any evidence I can find.
Two things are documented and worth acting on. Wear time is the real lever, and the sources disagree: BfR records that “Some manufacturers of nicotine pouches and snus recommend significantly shorter application times of 20 to 30 minutes”, while ZYN’s current product page says to “Leave the pouch in place for up to one hour”. A shorter hold means less extraction and less liquid. Format is the choice with real numbers behind it — a dry white product carries half the water of a moist portion and a tobacco-free dry pouch a tenth of it; white portion vs original portion is the comparison. Placement is the upper lip in every protocol and description I read, but no document advises the reader where to put it and nothing links placement to salivation, so treat placement as a comfort question rather than a drip one. And one thing is simply not documented: whether you get used to it. No study has looked at tolerance to salivation over time, and the only longitudinal signal points the other way, towards reduced resting flow in long-term users — gland adaptation rather than habituation.
What it does to your mouth, and where
The harms of snus to the mouth are real, well documented, and all at the contact site — not along the path the saliva takes. In 1,363 Norwegian adolescents, of whom 216 used snus daily, “Snus induced lesions were observed in 79.2% of daily snus using participants.” A German series of fifty habitual users found “lymphocytic infiltration, epithelial hyperplasia with keratinization, and varying degree of submucosal fibrosis” alongside gingival recession — and, importantly, “None of the individuals presented with symptoms specifically due to these mucosal changes.” The lesions are silent. The good news is that they go: they “are reversible, that is, clinical and histological tissue changes return to normal following cessation”, though “the exact mechanisms behind these changes are unknown” — from a study whose funding source is listed as Swedish Match AB while its authors declare no conflicts of interest.
And the drip itself has one documented benefit nobody expects. The 1991 occlusal-wear study found snuff protective against tooth wear, by exactly this route: the saliva “serves as a lubricant that protects the surface from wear”, and “It is concluded that the use of oral snuff is not an important risk factor in occlusal wear.” A 2005 comparison of forty users against forty matched non-users also found “no statistical differences between snuff users and non-users regarding restored tooth surfaces, presence of plaque, gingival inflammation and probing pocket depth.”
Set against that: no study anywhere examines the oesophagus, stomach or salivary glands in relation to swallowed snus saliva. The saliva pathway is simply not studied. Anybody who tells you confidently that swallowing it is harmful, or that it is harmless, is going beyond the evidence in one direction or the other.
Common questions
Should I spit or swallow? On the evidence, it does not much matter. One manufacturer says you may naturally swallow; one regulator describes the swallowed fraction as reabsorbable and does not warn against it; and the pharmacology says most of what you swallow is destroyed by your liver before it reaches your bloodstream.
Am I losing nicotine by swallowing? Some, not all. Swallowed nicotine is roughly 20–44% bioavailable against 100% intravenous, so about half to four-fifths of that fraction is wasted. The larger loss is the two thirds of a snus portion’s nicotine that never leaves the pouch at all.
Why does one brand drip far more than another? Water content — from around 3.5% in the driest tobacco-free pouch measured to 48–51% in a post-moisturised snus portion. And it does not mean you are using it wrong: a patent states that low bulk density is used specifically to promote salivation, because that is how the soluble ingredients get out. How long you keep it in is the lever that changes it.
For the whole format, start from what is snus. The strength question is what strength should a heavy smoker start on, and the ranked products are in the master ranking.
Sources
- Bundesinstitut für Risikobewertung, Health risk assessment of nicotine pouches, Opinion 023/2022, 7 October 2022 — the swallowed fraction, the extraction table, the poisonings case, the EFSA acute reference dose and the symptom tiers.
- Benowitz NL, Hukkanen J, Jacob P III, Nicotine chemistry, metabolism, kinetics and biomarkers, Handbook of Experimental Pharmacology, 2009 — bioavailability by route, ion trapping, first-pass metabolism. Supported by US Public Health Service grants from NIDA.
- Acute effects of snus in never-tobacco users: a pilot study, American Journal of Drug and Alcohol Abuse, 2018. n=11, within-subject, six doses including a nicotine-free pouch. Funded by a university psychology department and NIGMS T32 GM081741.
- Sellers EM et al., Hepatic CYP2A6 and nicotine bioavailability, Clinical Pharmacology & Therapeutics, 2000. Funding statement not obtainable; the journal is on a blocked host and the paper is not in PubMed Central.
- Benowitz NL et al., Determinants of nicotine intake while chewing nicotine polacrilex gum, Clinical Pharmacology & Therapeutics, 1987.
- Lunell E et al., Pharmacokinetic comparison of a novel non-tobacco-based nicotine pouch with conventional snus, Nicotine & Tobacco Research, 2020. The author list includes an affiliation at Product Science, Swedish Match; BfR records the study as manufacturer-financed. A verbatim funding statement could not be obtained.
- Pharmacokinetics of a nicotine sublingual tablet, European Journal of Clinical Pharmacology, 2001, and ileocolonic nicotine bioavailability, Alimentary Pharmacology & Therapeutics, 1997.
- Platt SP et al., Dissolution and physical characterization of oral nicotine pouch products, Scientific Reports, 2026 — release fractions, moisture and pore size. “This study was funded by Altria Client Services LLC, an affiliate of Helix Innovations LLC, the manufacturer of on! nicotine pouches,” which also has a disclosed interest in the owner of another brand in the set.
- McAdam K et al., Comparison of moisture and water measurement methods in smokeless tobacco products, BMC Chemistry, 2019 — Karl Fischer against oven volatiles, and the propylene glycol control. “The study was funded by British American Tobacco (BAT). At the time of the study KM, HK and AF were paid employees of BAT.”
- Swedish Match North Europe AB, EP 3 927 190 B1 (post-moisturising) and EP 3 192 380 A1 (pouch material, delayed release); Philip Morris Products S.A., EP 4 162 927 A1 (bulk density and salivation, wetting). European Patent Office publication server.
- British American Tobacco, US 2010/0200005 A1 — seepage, fleece spotting and packing machinery.
- Snus-induced lesions in Norwegian adolescents, Acta Odontologica Scandinavica, 2023, n=1,363; histopathology of snus-associated mucosal change, Virchows Archiv, 2026, n=50, “The authors declare no competing interests”; two case reports on tobacco-free pouches, BMC Oral Health, 2026, “No external funding received.”
- Oral mucosal lesions in snus users switching to tobacco-free nicotine pouches, European Journal of Oral Sciences, 2022 — funding source listed as Swedish Match AB; the authors declare no conflicts of interest.
- Is snuff a potential risk factor in occlusal wear?, Swedish Dental Journal, 1991; clinical and histological study of snuff-induced lesions, Scandinavian Journal of Dental Research, 1985; snuff users versus matched non-users, Oral Health & Preventive Dentistry, 2005; snus versus nicotine gum, Nicotine & Tobacco Research, 2011.
- Swedish Match, snus production; ZYN, US FAQ, a current product page and dry versus moist; Rogue, home page. All read 4 November 2026. Company sources.
Last verified 4 November 2026.
